Page last updated: 2024-09-02

ecteinascidin 743 and Neuroectodermal Tumors, Primitive

ecteinascidin 743 has been researched along with Neuroectodermal Tumors, Primitive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baruchel, S; Fox, E; Gonzalez, M; Hillewaert, V; Ouellet, D; Perez-Ruixo, JJ; Poggesi, I; Valenzuela, B	1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Neuroectodermal Tumors, Primitive

Article	Year
Population pharmacokinetics of trabectedin in adolescent patients with cancer. Cancer chemotherapy and pharmacology, 2019, Volume: 84, Issue:4 Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Alkylating; Body Surface Area; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Male; Medication Therapy Management; Neoplasms, Connective and Soft Tissue; Neuroectodermal Tumors, Primitive; Pediatrics; Trabectedin	2019

Article

Year

Population pharmacokinetics of trabectedin in adolescent patients with cancer.

Cancer chemotherapy and pharmacology, 2019, Volume: 84, Issue:4

Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Alkylating; Body Surface Area; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Male; Medication Therapy Management; Neoplasms, Connective and Soft Tissue; Neuroectodermal Tumors, Primitive; Pediatrics; Trabectedin

2019